← Back to Search

Behavioural Intervention

rtACS Stimulation for Glaucoma

N/A
Waitlist Available
Led By Heather Livengood, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 4
Awards & highlights

Study Summary

This trial will test whether an electric current intervention can help treat visual impairment for people with glaucoma and improve their quality of life.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Humphrey Visual Field Analyzer Score
Change in Macular Ganglion Cell-Inner Plexiform Layer Thickness
Change in Minnesota Low Vision Reading Test (MNRead): Reading Acuity Score
+17 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: rtACS Stimulation GroupExperimental Treatment1 Intervention
Group II: Sham Intervention GroupPlacebo Group1 Intervention
Sham stimulation looks like rtACS, but is not active rtACS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
rtACS Stimulation
2017
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,708 Total Patients Enrolled
7 Trials studying Glaucoma
1,681 Patients Enrolled for Glaucoma
Heather Livengood, PhDPrincipal InvestigatorNYU Langone Health
Joel Schuman, MD, FACSPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does one have to be of a certain age to participate in this trial?

"This clinical trial necessitates that enrollees are between the ages of 50 and 70. Additionally, there exist 23 trials for minors below 18 years old and 191 studies available to those aged 65 or above."

Answered by AI

Is it possible to become a participant in this research?

"This clinical trial is seeking 20 participants between the ages of 50 and 70 who have been diagnosed with glaucoma."

Answered by AI

Are there still opportunities to enroll in this research study?

"Affirmative, according to the information on clinicaltrials.gov this investigation is actively recruiting volunteers. It was first publicized in December 14th 2017 and has since been updated on January 28th 2022. 20 recruits are needed from 1 site for participation in the study."

Answered by AI

How many participants are participating in this medical research?

"Affirmative. According to the data published on clinicaltrials.gov, this particular medical study is currently recruiting volunteers with its first posting dated December 14th 2017 and most recent edit being January 28th 2022. A total of 20 individuals need to be enrolled from a single trial site."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
New York University School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma
2017. "A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03188042.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top